How Critical Illness Claims Are Assessed: What Insurers Look For

Critical illness (CI) insurance is designed to provide a lump sum on diagnosis of a serious condition, giving the insured financial support during illness and treatment. It is a valuable component of a comprehensive protection portfolio — but it is frequently misunderstood. Claims are assessed against precise clinical definitions, not simply against a named diagnosis, and this distinction is the source of many declined claims.

Understanding how the assessment process works — from the initial claim trigger through to payment — is essential for anyone relying on CI cover.

How a CI Claim Is Triggered

A CI claim is not triggered merely because the insured has been diagnosed with an illness that shares a name with one of the covered conditions. It is triggered when the insured's specific diagnosis satisfies the exact clinical definition set out in the policy contract.

This is the most important principle in critical illness insurance. The policy will list conditions such as 'cancer', 'heart attack', or 'stroke'. Beside each condition is a detailed clinical definition. The definition specifies the clinical criteria that must be met — histological grade, extent of invasiveness, specific biomarkers, area of cardiac damage, neurological deficit, and so on.

A diagnosis that does not meet every element of the definition does not trigger the claim, regardless of the severity of the insured's experience. This is not arbitrary — it reflects the actuarial pricing of the product. A CI policy priced to cover late-stage invasive cancer would be considerably more expensive than one that covers all cancer diagnoses including superficial and in-situ.

Cancer Definitions

Cancer is the most commonly claimed CI condition, and also the most common source of claim disputes. The critical distinction in most policies is between:

• Invasive cancer: a malignant tumour that has invaded surrounding tissue. This typically qualifies.
• In-situ cancer: cancer cells confined to the site of origin, not yet invasive. Most policies exclude in-situ cancers, or treat them as a partial payment condition.
• Early-stage, low-risk cancer: some specific cancers — early-stage prostate cancer (Gleason score below a specified threshold, T1 staging), papillary thyroid cancer below a defined diameter, and certain melanomas — are excluded or only partially covered in many policy wordings.

The precise boundary varies between providers and between policy generations. An older policy worded in the late 1990s or 2000s may have broader definitions than a policy written in 2020, where insurers had recalibrated definitions in response to claims experience on early-stage cancers. This is why reading the actual condition definition — not the headline summary — matters.

The Survival Period

Most CI policies include a survival period requirement: the insured must survive for a defined period after the date of diagnosis (or in some wordings, the date the insuring event occurred) before the claim is payable. The most common survival periods are 14 days and 30 days.

If the insured dies before the survival period expires, the CI claim does not pay. Instead, the death benefit pays under the life insurance element of the policy (if one is attached) or the policy lapses if it is a standalone CI policy.

The survival period exists to prevent the claim straddling both the CI and death benefit in ambiguous circumstances. For the vast majority of claimants who survive a serious illness diagnosis, the survival period is a procedural formality. For those in the most acute cases, it can affect the claim outcome significantly.

The Insurer's Assessment Process

When a CI claim is notified, the insurer's medical claims team initiates a structured assessment:

Step 1 — Initial review: the insurer reviews the notification and the stated diagnosis against the condition list to determine whether the claimed condition is covered in principle.

Step 2 — Medical records request: the insurer requests full medical records from the insured's treating physicians, hospitals, and consultants. The insured (or their legal representative) must consent to this release. Refusal to provide medical records will result in the claim being placed on hold or declined.

Step 3 — Clinical assessment: a qualified medical adviser employed by or contracted to the insurer reviews the records. They assess whether the diagnosis, staging, and clinical presentation satisfy the exact condition definition in the policy.

Step 4 — Independent medical examination (IME): for large claims, complex cases, or where records are incomplete or contradicted, the insurer may commission an IME. A specialist — typically in the relevant clinical field — examines the insured and provides an independent assessment. The insurer bears the cost; the insured is obliged to cooperate.

Step 5 — Outcome: the insurer issues a decision — claim accepted, partial payment offered, or claim declined — with written reasons.

Common Reasons CI Claims Are Declined

Beyond the clinical definition issue, CI claims are also declined for:

Diagnosis predating the policy: if the condition was diagnosed before the policy incepted, or if symptoms existed that should have been disclosed at application and would have led to an exclusion being applied, the claim may be declined on grounds of material non-disclosure.

Exclusion applied at underwriting: if the policy was issued with a specific medical exclusion — for example, excluding claims related to a pre-existing cardiac condition — and the claim arises from that excluded condition, it will not pay.

Survival period not met: as above.

Condition not meeting the definition: the most frequent reason. The insured has a genuine and serious illness, but the clinical presentation does not satisfy every element of the policy's definition.

Partial Payment Conditions

An increasing number of international CI policies include a partial payment structure for less severe but still significant diagnoses. Under this structure, a defined percentage of the sum assured — commonly 25% — is paid for specified conditions, and the base policy continues in force for the remaining 75%.

Examples of conditions typically covered under partial payment provisions include:

• Early-stage prostate cancer (meeting specific clinical criteria that do not meet the full cancer definition).
• Low-severity coronary artery disease, confirmed by angiography.
• Mild heart attack with limited troponin elevation.
• Carcinoma-in-situ of specific sites.

Partial payment provisions improve the practical value of CI cover by providing financial support for serious conditions that fall short of the full claim trigger. When comparing policies, check whether partial payment provisions are included and which conditions are covered.

The Insurer's Right to a Second Opinion

Where the insured disagrees with the outcome of the insurer's medical assessment, they are entitled to provide additional medical evidence — a second specialist opinion, updated clinical records, or expert commentary on the condition definition. The insurer is obliged to consider this additional evidence.

The second opinion should ideally come from a consultant specialising in the clinical area relevant to the claim (oncology for cancer claims; cardiology for cardiac claims), and should address directly whether the clinical presentation meets the policy's specific definition.

Challenging an Incorrect Decision

If the insurer's decision appears incorrect — based on the policy wording and clinical evidence — the insured or their representative should:

1. Request a formal internal review through the insurer's complaints process.
2. If the internal review upholds the decline, refer the complaint to the relevant ombudsman.
3. For Isle of Man-regulated policies, the IoM Financial Services Ombudsman scheme provides independent adjudication.
4. For UK-regulated firms serving UK consumers, the UK Financial Ombudsman Service may have jurisdiction.
5. As a last resort, court proceedings can be initiated, though this is rarely necessary if the ombudsman route is pursued.

Professional support from an insurance claims solicitor or an experienced protection adviser is valuable at the internal review stage. Many declined claims that initially appear clear-cut are overturned when the clinical evidence is properly presented against the precise policy wording.

---

This guide is for information only and does not constitute legal or financial advice. Condition definitions, survival periods, and partial payment structures vary between providers and between policy generations. Always read the full condition definitions in your specific policy document before relying on the cover.

How Global Investments Can Help

Our advisers understand the detailed condition definitions used by each provider on our panel. When recommending a CI policy, we explain the specific definition for the most commonly claimed conditions — cancer, heart attack, and stroke — in plain language, so clients understand what the policy will and will not cover.

For existing policyholders facing a claim or a declined claim, we can review the policy wording, assist in compiling the medical evidence file, and guide you through the internal complaints or ombudsman process. Contact our protection team for assistance.